Frau Pharma
Italian pharmaceutical manufacturer founded in 2011 near Milan, producing high-purity APIs (Levosimendan, Carfilzomib, Fenfluramine, Teriflunomide, Maribavir) and branded nutraceutical ingredients through GMP-certified facilities, serving pharmaceutical and nutraceutical companies globally.
- Company typePrivate
- Founded2011
- HeadquartersAgrate Brianza, Italy
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Frau Pharma does
Frau Pharma is an Italian pharmaceutical and nutraceutical manufacturer founded in 2011 and headquartered in Agrate Brianza near Milan. The company researches, develops, and produces high-purity active pharmaceutical ingredients (APIs) and branded nutraceutical ingredients, specializing in lipid and phospholipid chemistry. Its pharmaceutical portfolio spans five APIs across cardiovascular, immunoregulatory, anti-cancer, antiviral, and CNS indications: Levosimendan (acutely decompensated congestive heart failure), Teriflunomide (relapsing-remitting multiple sclerosis), Carfilzomib (multiple myeloma), Fenfluramine (Dravet and Lennox-Gastaut syndromes, produced via a proprietary patented heavy-metal-free process), and Maribavir (post-transplant CMV). Its nutraceutical portfolio is sold under five registered trademarks: NEUROPEAK® (Phosphatidylserine), REPEA® (Palmitoylethanolamide), VIVIBEN® (Oleoylethanolamide), FolMidable® (L-5-Methyltetrahydrofolate), and SEMPREVITAL® (Spermidine).
The company operates a 10,000 m² manufacturing campus that includes 800 m² of R&D and QC laboratories, three dedicated production units with Class C and D cleanrooms, 21 reactors ranging from 50 L to 3,000 L, lyophilization capability, and a dedicated high-potency drug production unit. Analytical and quality control capabilities span X-Ray Crystallography, DSC, Laser Diffractometry, NMR, HPLC-MASS, GC-MASS, ELISA, and Real-Time PCR. The site holds GMP certification and is authorized by AIFA (Italian Medicines Agency) and inspected by the FDA Dietary Ingredients Division, with additional GLP, HACCP, and ICH CF21 compliance. APIs are registered with Drug Master Files at multiple health authorities, and the company offers registration dossier licensing (e.g., Levosimendan 12.5 mg vial) and contract manufacturing services covering clinical trial batches, first industrial batches, and process/analytical validation.
Frau Pharma operates as a private, founder-controlled Italian SRL generating revenue through direct B2B sales of bulk APIs and bulk nutraceutical ingredients to pharmaceutical and nutraceutical companies worldwide, supplemented by dossier licensing and contract manufacturing service fees. Distribution is exclusively direct (no third-party distributors or resellers), executed via enterprise field sales supported by the company website, downloadable brochures, LinkedIn and Instagram presence, and inbound inquiry through info@, sales@, and product-specific contact forms. Pricing is quote-based, calibrated to order quantity, purity, assay, and packaging, with no publicly disclosed prices. The company's stated markets served are global, with no geographic restrictions on record.
Frau Pharma firmographics
Firmographics- Name
- Frau Pharma
- Legal name
- Frau Pharma srl
- Website
- https://fraupharma.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Italian pharmaceutical manufacturer founded in 2011 near Milan, producing high-purity APIs (Levosimendan, Carfilzomib, Fenfluramine, Teriflunomide, Maribavir) and branded nutraceutical ingredients through GMP-certified facilities, serving pharmaceutical and nutraceutical companies globally.
- Ownership category
- akta.pro rank
Frau Pharma industry classification
Industry- Product category
- Pharmaceutical API and Nutraceutical Ingredient Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)
Keywords
Where Frau Pharma is headquartered
LocationHeadquarters
- HQ city
- Agrate Brianza
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
Frau Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Active Pharmaceutical Ingredients (APIs) Manufacturing: Frau Pharma generates revenue by manufacturing and supplying high-purity APIs including Levosimendan, Teriflunomide, Carfilzomib, Fenfluramine, and Maribavir to pharmaceutical companies. Products are sold in bulk powder form for generic drug development with DMF registered with Health Authorities.
- Nutraceutical Ingredients Manufacturing: Revenue is generated from manufacturing and supplying nutraceutical ingredients including Phosphatidylserine (NEUROPEAK®), Palmitoylethanolamide (REPEA®), Oleoylethanolamide (VIVIBEN®), Methyltetrahydrofolate (FolMidable®), and Spermidine (SEMPREVITAL®) to nutraceutical companies in bulk quantities.
- Registration Dossier Licensing: Frau Pharma offers registration dossiers for licensing, such as the Levosimendan 12.5mg vial registration dossier, providing additional revenue stream through intellectual property licensing.
- Contract Manufacturing Services: The company provides contract manufacturing services including production of clinical trial batches, first industrial batches for NDA, and process and analytical validation to support regulatory submissions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Bulk powder orders with customizable packaging |
| Unit Pricing | Pay-as-you-go | USP grade calcium L-5-Methyltetrahydrofolate bulk supply |
| Unit Pricing | Pay-as-you-go | Oleoylethanolamide bulk powder (VIVIBEN®) |
| Unit Pricing | Pay-as-you-go | Multiple PEA formulations for diverse applications |
| Unit Pricing | Pay-as-you-go | Phosphatidylserine from sunflower or non-GMO soy |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Frau Pharma product offering
Product offeringCore offering
Frau Pharma manufactures high-purity active pharmaceutical ingredients (APIs) and proprietary branded nutraceutical ingredients, with a specialization in lipid and phospholipid chemistry. The company provides contract research, development, manufacturing, and quality control services, along with registration dossier support, to pharmaceutical and nutraceutical companies worldwide. Its manufacturing operations are GMP-certified and inspected by major regulatory authorities including AIFA and FDA.
Product overview
Frau Pharma is a pharmaceutical and nutraceutical company founded in 2011 near Milan, Italy, specializing in the research, development, and manufacturing of high-quality ingredients. The company operates a portfolio of branded nutraceutical products (NEUROPEAK® Phosphatidylserine, REPEA® Palmitoylethanolamide, VIVIBEN® Oleoylethanolamide, FolMidable® Methyltetrahydrofolate, SEMPREVITAL® Spermidine) and pharmaceutical APIs (Levosimendan, Teriflunomide, Carfilzomib, Fenfluramine, Maribavir). The offering is complemented by three core service pillars: Research & Development (API and nutraceutical development with advanced analytical equipment), Manufacturing (GMP-certified production facilities with 10,000 m² site, 21 reactors, and high-potency drug capabilities), and Quality Control (GMP/GLP/HACCP compliant testing with full microbiological and analytical chemistry departments). The company positions itself as a B2B supplier to pharmaceutical and nutraceutical industries, providing bulk ingredients, contract manufacturing, and regulatory support.
Differentiator
Problem solved
Functional benefit
Brands
- NEUROPEAK®: Phosphatidylserine (PS) supplement brand for cognitive health, mood enhancement, and physical performance support.
- REPEA®
- VIVIBEN®
- FolMidable®
- SEMPREVITAL®
Products and services
- NEUROPEAK® Phosphatidylserine
- REPEA® Palmitoylethanolamide
- VIVIBEN® Oleoylethanolamide
- FolMidable® Methyltetrahydrofolate
- SEMPREVITAL® Spermidine
- Levosimendan API
- Teriflunomide API
- Carfilzomib API
- Fenfluramine API
- Maribavir API
- Contract Manufacturing Services
- Research and Development Services
- Quality Control and Analytical Services
- Registration Dossier Services
Quantifiable outcome
- Spermidine supplementation associated with 5.7 years longer life expectancy in clinical observation studies (Stefan et al., 2018)
- +3 more outcomes
Companies that use Frau Pharma
Customer profileSegments3 records
Ideal customer profiles2 records
Frau Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Frau Pharma partnerships and signals
Strategic signalScale indicators6 records
Recent moves6 records
Expansion highlights5 records
Frau Pharma competitors and assessment
Company assessmentBroad incumbents
- Polpharma Biologics: Large European generics and API manufacturer. Broad incumbent operating at significantly larger scale but overlapping in generic API supply, including CNS and cardiovascular molecules.
- Divis Laboratories: Large Indian API manufacturer serving global generic pharmaceutical customers. Broad incumbent whose scale and cost position represent a structural pricing competitor for small-molecule API contracts.
Direct peers
- Olon SpA: Major Italian CDMO and generic API manufacturer, headquartered in Milan area. Direct peer based on overlap in small-molecule API manufacturing, GMP capabilities, and shared Italian/European regulatory positioning.
- Cerbios-Pharma SA: Swiss CDMO specialized in HPAPI (high-potency active pharmaceutical ingredients) and biologics. Direct peer given shared high-potency production capability, GMP focus, and small-molecule API expertise.
- CordenPharma: European CDMO offering API manufacturing, including high-potency and complex small molecules. Direct peer given overlapping capability set (GMP API manufacturing, contract development) and shared focus on regulated pharmaceutical customers.
- Fabbrica Italiana Sintetici (FIS): Italian API manufacturer and contract manufacturer based in Vicenza. Direct peer sharing geographic base, GMP-certified small-molecule API production, and a similar customer base of generic pharmaceutical companies.
- Siegfried Holding AG: Swiss-listed CDMO with API and finished dose manufacturing. Direct peer in small-molecule API manufacturing for the generic and innovator pharmaceutical market, with comparable regulatory credentials (FDA, EMA).
- Farmhispania Group: Spanish API manufacturer (acquired by Aurobindo). Mid-sized European API peer with comparable GMP capabilities, contract manufacturing services, and generic-pharma customer focus.
- Medichem SA: Spanish API manufacturer with GMP facilities supplying generic and innovative pharmaceutical companies. Direct peer in small-molecule API manufacturing with comparable regulatory inspection history.
Emerging players
- AIDP Inc. US-based supplier of branded nutraceutical ingredients including phospholipids and other science-backed bioactives. Emerging player in the nutraceutical ingredient space, with overlapping products (e.g., Phosphatidylserine) and a similar B2B branded-ingredient model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Frau Pharma social profiles
Digital presenceFrau Pharma compliance and trust
Trust signalCompliance4 records
Frau Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Frau Pharma leadership team
Management profileNumber of profiles
Frau Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Frau Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Frau Pharma
What does Frau Pharma do?
Frau Pharma manufactures high-purity active pharmaceutical ingredients (APIs) and proprietary branded nutraceutical ingredients, with a specialization in lipid and phospholipid chemistry. The company provides contract research, development, manufacturing, and quality control services, along with registration dossier support, to pharmaceutical and nutraceutical companies worldwide. Its manufacturing operations are GMP-certified and inspected by major regulatory authorities including AIFA and FDA.
Is Frau Pharma a public or private company?
Frau Pharma is a private company. It is classified as unknown and is currently operating.
When was Frau Pharma founded?
Frau Pharma was founded in 2011. It employs 11 to 50 people.
Where is Frau Pharma based?
Frau Pharma is headquartered in Agrate Brianza, Italy, in the Europe region.
How does Frau Pharma make money?
Four revenue lines are on record. Active Pharmaceutical Ingredients (APIs) Manufacturing is the primary driver. The others are nutraceutical Ingredients Manufacturing, registration Dossier Licensing and contract Manufacturing Services.
Who are Frau Pharma's main competitors?
Broad incumbents on record are Polpharma Biologics and Divis Laboratories. Direct peers are Olon SpA, Cerbios-Pharma SA, CordenPharma, Fabbrica Italiana Sintetici (FIS), Siegfried Holding AG, Farmhispania Group and Medichem SA. AIDP Inc. is listed as an emerging player.
Does Frau Pharma have an API?
No public API is recorded for Frau Pharma.
What industry is Frau Pharma in?
Frau Pharma's product category is Pharmaceutical API and Nutraceutical Ingredient Manufacturing. Its primary akta.pro industry code is HLAGAHAL, GMP Scale-Up, Tech Transfer & Process Validation (PPQ). Its NAICS code is 325412 and its SIC code is 2833.